Chronic kidney disease (CKD) affects an estimated 30 to 40 percent of cats over the age of 10, making it one of the most common and consequential conditions in feline medicine. Despite its prevalence, CKD is frequently diagnosed late — often when 65 to 75 percent of functional nephron mass has already been lost. By that point, treatment options are largely palliative.
The challenge is not a lack of awareness. Most veterinary professionals know CKD is common in aging cats. The challenge is that early-stage kidney disease is clinically silent, and the tools we have traditionally relied on for detection have significant limitations in the subclinical window.
The Problem with Late Diagnosis
Cats are remarkably good at compensating for declining renal function. Serum creatinine, the most commonly used marker of kidney function, does not reliably rise above the reference range until approximately 75 percent of nephron function is gone. This means a cat can lose the majority of its kidney function and still have bloodwork that looks normal.
By the time clinical signs appear — increased thirst, weight loss, poor appetite, vomiting — the disease has often progressed to IRIS Stage 3 or 4. At these stages, management focuses on slowing progression and maintaining quality of life rather than meaningful intervention.
Why Early Detection Changes Outcomes
Research has consistently shown that cats diagnosed at IRIS Stage 1 or early Stage 2 have significantly longer survival times compared to those diagnosed at later stages. Early detection opens the door to:
- Dietary management — Renal diets have been shown to slow progression when started early
- Blood pressure monitoring — Hypertension is a common and treatable complication of CKD
- Phosphorus management — Early phosphorus restriction is associated with slower disease progression
- Hydration support — Subcutaneous fluids can be started before dehydration becomes a chronic issue
- SDMA and trend monitoring — Serial monitoring of renal biomarkers allows detection of progression before clinical signs worsen
The difference between catching CKD at Stage 1 versus Stage 3 can mean years of additional quality life for a patient.
Current Screening Approaches
The International Society of Feline Medicine (ISFM) and the Feline Veterinary Medical Association (FVMA) both recommend annual wellness screening for cats over 7 years of age, with more frequent screening for senior cats over 11. A comprehensive renal screening panel typically includes:
- Serum creatinine and BUN — Traditional markers, though limited in early disease
- SDMA (Symmetric Dimethylarginine) — A newer biomarker that may detect reduced GFR earlier than creatinine
- Urinalysis with USG — Urine specific gravity (USG) is one of the earliest indicators of concentrating ability loss
- Urine protein-to-creatinine ratio (UPC) — Identifies proteinuria, which is both a marker and a progression factor
- Blood pressure measurement — Screens for renal hypertension
Of these, urine specific gravity is particularly valuable because the kidneys' ability to concentrate urine is one of the first functions to decline, often before azotemia develops.
The Screening Gap
Despite clear guidelines, routine screening uptake remains inconsistent. Some of the barriers include:
- Owner compliance — Many cat owners do not bring their cats in for routine wellness visits, particularly if the cat appears healthy
- Cost — A full renal panel with urinalysis adds cost to a wellness visit
- Sample collection — Obtaining a urine sample from a cat can be logistically difficult, especially in the home environment
- Interpretation — Mild changes in USG or SDMA require context and trending to be clinically meaningful
These barriers mean that many cats do not receive screening until they are already symptomatic.
A Role for AI-Assisted Screening
This is the problem space that motivated us to build RadAnalyzer USG Screening. By analyzing routine bloodwork values that are already being collected during wellness visits, we can flag cats that are likely to have a low urine specific gravity — and therefore may have early renal compromise — even when a urine sample was not collected.
This does not replace urinalysis. It supplements it by identifying which patients most urgently need follow-up renal workup, helping clinicians prioritize their screening efforts where they matter most.
We are currently piloting this approach at Memorial Cat Hospital in Houston, Texas, and are in the process of onboarding two additional Texas clinics to expand our validation efforts. We will be sharing results as the data matures. If you are interested in feline kidney screening, we encourage you to explore our free Feline Kidney Screening Tool and stay tuned for updates.
Key Takeaways
- CKD is the most common cause of death in older cats, but early detection is achievable
- Serum creatinine alone misses the majority of early-stage disease
- USG, SDMA, and serial monitoring are critical for catching CKD before clinical signs
- AI-assisted screening can help bridge the gap between available bloodwork and missing urinalysis data
- Earlier intervention leads to longer, better quality lives for feline patients